DGX vs HURA · P/E 22, rev $5.94B vs $125.1M cap
Quest Diagnostics Incorporated (DGX) versus TuHURA Biosciences Inc (HURA) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
TuHURA Biosciences Inc (HURA) is a biotechnology company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported HURA revenue for 2026-03-31 was $0. Net income was -$7.5M. HURA currently screens at market cap $125.1M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. HURA currently screens at market cap $125.1M.
Not investment advice. Open the DGX and HURA stock pages for the full models.
Not investment advice.